FEBRUARY 17, 2021
Accelerating Solutions for COVID-19 Response
Access over 60 solution providers pitching their innovations in the areas of Oxygen delivery and SARS-CoV-2 Detection and Diagnostics. Based on TechConnect Venture's COVID Sprint Series, this program is designed to accelerate emerging technologies addressing key challenges posed by the ongoing COVID-19 health crisis. Connect through one-on-one video chats with these innovators, and help us move their solutions into the marketplace and society.
COVID SPOTLIGHT SUMMIT - DAY AT-A-GLANCE
All times listed are in Eastern Standard Time. Program is Subject to Change
10:00am - 10:15am (EST)
Welcome & Opening
TechConnect Ventures - COVID Sprints Overview
10:15am - 11:05am (EST)
|
DIAGNOSTICS I (Detailed Program) (Sprint Summary)
|
11:05am - 12:05pm (EST)
|
DIAGNOSTICS II (Detailed Program) (Sprint Summary)
|
|
12:05pm - 1:10pm (EST)
|
DETECTION (Detailed Program) (Sprint Summary)
|
|
1:10pm - 2:00pm (EST)
|
OXYGEN DELIVERY (Detailed Program) (Sprint Summary)
|
|
2:00pm - 2:05pm (EST)
Closing Remarks - TechConnect
COVID SPOTLIGHT SUMMIT - DETAILED PROGRAM
Matt Laudon, CEO, TechConnect
Nick Kacsandi, Executive Director, TechConnect Ventures
Diagnostic Technologies for SARS-CoV-2 Session 1 - Overview
Jennifer Rocha, Vice President, Strategic Partnerships, TechConnect
Mike Stebbins, Executive Director, MCDC (Medical CBRN Defense Consortium) and CWMD (Countering Weapons of Mass Destruction Consortium), ATI
Innovation Spotlight Pitches - Diagnostics I
A Rapid Handheld Diagnostic Device for SARS-CoV-2 in Patient Saliva Samples, OmniVis Inc., California
Rapid identification of Coronaviruses including SARS-CoV-2 and detection of its mutations, Z-Field Technologies LCC, California
Vyrionix™ Real-Time, Smart Infection Monitoring System, Khyron Technologies, California
CoTest - Cohort Testing at the point of highest impact, TTP, United Kingdom
CONQUEST (COroNavirus QUick and Easy Saliva/swab Test), University of Nottingham, United Kingdom
Rapid Antigen Test for COVID-19 Diagnosis at the Point of Care, Kephera Diagnostics, LLC, Massachusetts
A CRISPR-based rapid and sensitive test for COVID-19, University of Florida, Florida
Veralize - Universal Nucleic Acid Detection Platform, 12-15 Molecular Diagnostics, Inc. (12-15MD), Connecticut
C-FAST: Rapid point-of-care molecular test in test strip format for COVID-19, Raytheon BBN, Massachusetts
HIGH-PRECISION SARS-COV-2 MOLECULAR DETECTION AND COVID-19 DIAGNOSTICS, Wayne State University, Michigan
PCR Virus Scanner for Rapid and Accurate COVID 19 Test, Novus XYZ Scan, North Carolina
A rapid, inexpensive and operator-friendly kit for SARS-COV-2 detection in saliva samples, Tissue Click Ltd, United Kingdom
COVID-19 detection using an ultra-fast breath test, Callaghan Innovation and SYFT Technologies Ltd, New Zealand
Low-cost Biosensor for Rapid Detection of SARS-CoV-2 at the Point-of-Care, University of Pennsylvania, Pennsylvania
Diagnostic Technologies for SARS-CoV-2 Session 2 - Overview
Jennifer Rocha, Vice President, Strategic Partnerships, TechConnect
Kathy Zolman, Director, MTEC (Medical Technology Enterprise Consortium), ATI
Wendy Sammons-Jackson, Director within the Medical and Software Services Division, ATI
Innovation Spotlight Pitches - Diagnostics II
A Point-of-Care device for fast and cost-effective molecular testing of SARS-CoV2 in nasal samples, Nanoplasmas P.C., Greece
Whole Virus Detection As Direct Marker For Infectivity Potential, Cleveland Diagnostics, Inc., Ohio
Ultra-sensitive Microbubbling SARS-CoV-2 Antigen Detection with Smartphone, Instanosis, Inc., Pennsylvania
COVID-19 Detection using Nanotechnology Based Devices, Jadoo Technologies Inc, California
Biosensing for Screening, Diagnosis and Monitoring of SARS-CoV-2 from saliva samples, OptDx Inc., California
Rapid Saliva Detection for Covid-19 Virus, Transversal Therapeutics, Massachusetts
FastPCR for portable, rapid disease detection, Lawrence Livermore National Laboratory, California
Point-of-care technology to provide risk assessment for Covid-19, Salcit Technologies Private Limited, India
15 minutes to result with consumer grade SARS-CoV-2 molecular self-test at home, midge medical GmbH, Germany
Rapid, multiplexed detection of SARS-CoV-2 and other viral infections with high-quality-factor (high-Q) nanophotonics, Stanford University, California
Rapid COVID-19 Diagnostic Platform Using Saliva, ni2o, inc., Rhode Island
GeneTiger, GeneTiger, Texas
Disposable Integrated Photonics Diagnostics Platform for Next Generation Biosensing (i.e. COVID-19), SiPhox, Inc., Massachusetts
A Biosensor that can Rapidly Detect Airborne Viruses and Bacteria, Phoenix Biometrics, Inc., Arizona
Detection Technologies for SARS-CoV-2 - Overview
Nick Kacsandi, Executive Director, TechConnect Ventures
Innovation Spotlight Pitches - Detection
Device for rapid and accurate detection of CoV-2 virus from environmental samples., Levi Diagnostics, Inc., Massachusetts
Detecting SARS-CoV2 using a Novel Real-Time Bioluminescent Assay, University of Houston, Texas
Automated In-Situ Detection of Airborne SARS-CoV-2 and other viruses, Kromek Ltd, United Kingdom
Shipboard wastewater-based epidemiology for rapid detection of COVID-19 and other pathogens, InnovPrep LLC, Missouri
Non-Invasive Super-Rapid Automatic Viral Infection Detection, Roboscientific Ltd., United Kingdom
Novel concentrator to capture airborne viral particles, Rutgers University, New Jersey
Plasmonic sensor for label-free detection of individual SARS-CoV2 particles and acompanying bacterial pathogenes in liquid samples, Leibniz-Institut für Analytische Wissenschaften - ISAS-e.V., Germany
Immediate Covid-19 Screening and Control of Airborne Spreading, SINHATECH, Mississippi
Photo-electric ELISA Using Silicon Nanowire Arrays, Advanced Silicon Group, Massachusetts
Air-borne SARS CoV-2 detection and Identification, NanoBio Devices Inc. (NBD), Taiwan
Rapid Identification and Detection of Virus from Environmental Sample, weeDetect LLC, Arkansas
Rapid detection of SARS-CoV-2 using handheld NMR of shape-defined magnetic particles, Weinberg Medical Physics, Inc., Maryland
A simple colorimetric on site COVID 19 detection kit from environmental samples, Institute of Chemical Technology, India
Technologies for O2 Delivery & Therapy - Overview/Challenge
Nick Kacsandi, Executive Director, TechConnect Ventures
Mike Hess, Senior Director of Patient Outreach and Education, COPD Foundation
Innovation Spotlight Pitches - Oxygen Delivery
Portable, chemical oxygen generator for emergency use, Rapid Oxygen Company, Connecticut
Therapeutic Supplemental Oxygen Delivery in COVID-19, Respirogen, Inc., Colorado
HemeOx™: The First Clinically-Accurate Total Hemoglobin Pulse Oximeter – The Complete Oxygen Monitoring Picture!, Kestrel Labs, Inc., Colorado
Local production of oxygen concentrators, ETH Zürich, Switzerland
AutO2, Vanderbilt University, Tennessee
Portable Controllable High Flow Rate Sterile Air System, MetCel LLC, Oklahoma
Ox66™ - a Novel COVID-19 Therapeutic, Hemotek, LLC, Texas
High flow Oxygen Concentrator with remote Adjustment, National Services Scotland, United Kingdom
Solid State USP-Grade Oxygen Generators, American Oxygen, Utah
Oxygen Swing Absorption, Department of Physics Chemistry and Pharmacy, University of Southern Denmark, Denmark
Vespirator-New Class of Breathing Device for COVID-19 and Other Respiratory Care, Legacy US, Inc, Idaho
High Flow Non-Invasive Oxygen Therapy System - GranFlow, University of Granada, Spain
Multi-powered ventilation or oxygen delivery apparatus, Stackpoint Technology Solutions (LLC ready to launch), New York
Portable Oxygen Concentrator with remote monitoring and flow adjusting, Advanced Interactive Response Systems (AIRS), Michigan
Roboventilator, Carnegie Mellon University, Pennsylvania
Nick Kacsandi, Executive Director, TechConnect Ventures
 |
 |
© Copyright 2021 TechConnect. All Rights Reserved.
Disclaimer |
Privacy Policy | Terms of Use
All Department of Defense speakers are subject to budget travel changes.
*Participation by any United States Federal Agency in any TechConnect activity or event does not constitute an expressed or implied endorsement of any cosponsor, donor, grantee, contractor or participant’s opinions, products, or services.
Produced by 
|
In Partnership with 
|
|